BG106985A - Compounds having anti-tumor activity, process for their preparation and pharmaceutical compositions containing them - Google Patents

Compounds having anti-tumor activity, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
BG106985A
BG106985A BG106985A BG10698502A BG106985A BG 106985 A BG106985 A BG 106985A BG 106985 A BG106985 A BG 106985A BG 10698502 A BG10698502 A BG 10698502A BG 106985 A BG106985 A BG 106985A
Authority
BG
Bulgaria
Prior art keywords
compounds
preparation
pharmaceutical compositions
compositions containing
tumor activity
Prior art date
Application number
BG106985A
Other languages
Bulgarian (bg)
English (en)
Inventor
Srinivas Nanduri
Sriram Rajagopal
Sairam Pothukuchi
Sunilkumar PILLAI
Ranjan Chakrabarti
Original Assignee
Dr. Reddy's Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy's Laboratories Limited filed Critical Dr. Reddy's Laboratories Limited
Publication of BG106985A publication Critical patent/BG106985A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • AIDS & HIV (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG106985A 2000-02-03 2002-08-07 Compounds having anti-tumor activity, process for their preparation and pharmaceutical compositions containing them BG106985A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN89MA2000 2000-02-03
PCT/IB2001/000127 WO2001057026A1 (en) 2000-02-03 2001-02-02 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
BG106985A true BG106985A (en) 2003-04-30

Family

ID=11097156

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106985A BG106985A (en) 2000-02-03 2002-08-07 Compounds having anti-tumor activity, process for their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US6410590B1 (xx)
EP (1) EP1261604A1 (xx)
JP (1) JP2003522166A (xx)
KR (1) KR20030004342A (xx)
CN (1) CN1416428A (xx)
AU (1) AU3043101A (xx)
BG (1) BG106985A (xx)
BR (1) BR0108064A (xx)
CA (1) CA2398996A1 (xx)
CZ (1) CZ20022655A3 (xx)
HU (1) HUP0204347A3 (xx)
IL (1) IL150905A0 (xx)
MX (1) MXPA02007513A (xx)
NO (1) NO20023643L (xx)
NZ (1) NZ520521A (xx)
RU (1) RU2002123576A (xx)
WO (1) WO2001057026A1 (xx)
ZA (1) ZA200206112B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576662B2 (en) * 2000-05-05 2003-06-10 Dr. Reddy's Laboratories Limited Compounds having anticancer activity : process for their preparation and pharmaceutical compositions containing them
CN100430054C (zh) * 2002-12-31 2008-11-05 北京大学第一医院 穿心莲二萜内酯在制备抑制血管生成药物中的应用
CN100408571C (zh) * 2003-02-25 2008-08-06 北京医工生物技术研究所 穿心莲内酯三马来酸半酯及其盐和它们的药物组合物
AU2004315105A1 (en) * 2004-02-03 2005-08-18 Universidad Austral De Chile Composition of labdane diterpenes extracted from Andrographis paniculata, useful for the treatment of autoimmune diseases, and Alzheimer disease by activation of PPR-gamma receptors
JP5049788B2 (ja) * 2004-11-08 2012-10-17 コーネル リサーチ ファンデーション インコーポレーティッド ウイルス感染症を処置するためのアンドログラフォライド（ａｎｄｒｏｇｒａｐｈｏｌｉｄｅ）誘導体
CN101129354B (zh) * 2005-06-06 2011-02-02 河南大学 含有三乙酰穿心莲内酯的药物组合物及其医药用途
JP2007176934A (ja) * 2005-11-30 2007-07-12 Kose Corp 血小板活性化因子アセチルヒドロラーゼ機能調整剤
CN101481375B (zh) * 2005-12-07 2011-06-01 郑州大学 穿心莲内酯c15位取代系列衍生物及其制备方法
CN100999520B (zh) * 2007-01-05 2010-12-01 郑州大学 异穿心莲内酯类似物及其制备方法
KR101444497B1 (ko) 2007-05-31 2014-09-24 산토리 홀딩스 가부시키가이샤 안드로그라폴라이드를 유효 성분으로 하는 항피로제 및 경구 조성물
CN100584841C (zh) * 2007-08-08 2010-01-27 暨南大学 穿心莲内酯衍生物及其在制药中的应用
US20090117209A1 (en) * 2007-11-02 2009-05-07 Hutchison Medipharma Enterprises Limited Andrographis paniculata extract
US9060994B2 (en) 2011-12-21 2015-06-23 Inno Biosciences, S.p.A. Combination therapy with interferon and andrographolides for Multiple Sclerosis
CN102526026B (zh) * 2012-02-10 2013-07-03 郑州大学 15-苄亚基-14-脱氧-11,12-脱氢穿心莲内酯衍生物在制备保肝药物中的用途
WO2016065264A1 (en) * 2014-10-24 2016-04-28 Biogen Ma Inc. Diterpenoid derivatives and methods of use thereof
CN106606506A (zh) * 2015-10-21 2017-05-03 复旦大学 对映半日花烷型二萜在制备抗补体药物中的用途
CN105954457A (zh) * 2016-06-24 2016-09-21 广西灵峰药业有限公司 一种金香胶囊的生产质量控制方法
CN109942520B (zh) * 2019-04-10 2023-08-01 大理金明动物药业有限公司 穿心莲内酯磺化物及其制备方法与应用
CN116898841A (zh) * 2023-09-11 2023-10-20 中国中医科学院广安门医院 一种穿心莲内酯改构化合物l8或其衍生物的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6388124A (ja) 1986-09-30 1988-04-19 Toyo Jozo Co Ltd 抗腫瘍剤
GB8917295D0 (en) 1989-07-28 1989-09-13 Ruffles Graham K Anti-viral compositions
AU4376396A (en) 1994-12-06 1996-06-26 Paracelsian, Inc. Use of andrographolide compounds to treat or prevent pathogenicity of diseases

Also Published As

Publication number Publication date
AU3043101A (en) 2001-08-14
CZ20022655A3 (cs) 2003-04-16
NO20023643L (no) 2002-09-30
WO2001057026A1 (en) 2001-08-09
CN1416428A (zh) 2003-05-07
BR0108064A (pt) 2002-10-29
ZA200206112B (en) 2003-10-31
JP2003522166A (ja) 2003-07-22
KR20030004342A (ko) 2003-01-14
HUP0204347A2 (en) 2003-05-28
US6410590B1 (en) 2002-06-25
HUP0204347A3 (en) 2005-04-28
US20020032229A1 (en) 2002-03-14
NO20023643D0 (no) 2002-07-31
NZ520521A (en) 2004-05-28
IL150905A0 (en) 2003-02-12
EP1261604A1 (en) 2002-12-04
MXPA02007513A (es) 2004-08-23
CA2398996A1 (en) 2001-08-09
RU2002123576A (ru) 2004-01-10

Similar Documents

Publication Publication Date Title
BG106985A (en) Compounds having anti-tumor activity, process for their preparation and pharmaceutical compositions containing them
MY128659A (en) Novel aminodicarboxylic acid derivatives having pharmaceutical properties
IL148103A0 (en) Novel dicarboxylic acid derivatives with pharmaceutical properties
HK1060117A1 (en) Taxol enhancer compounds
CA2374247A1 (en) Heterocyclic derivatives useful as anticancer agents
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
HUT62893A (en) Process for producing substituted pyrimidine derivatives and pharmaceutical compositions comprising such compounds as active ingredient
BG104998A (en) Isothiazole derivatives useful as anticancer agents
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
EP1256588A4 (en) NEW PYRAZINE DERIVATIVES OR SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THE DERIVATIVES OR THEIR SALTS AND INTERMEDIATES FOR BOTH PRODUCTION
HUT61004A (en) Process for producing quinoxaline derivatives and pharmaceutical compositions comprising such compounds as active ingredient
IL165181A (en) Use of substituted cyanopyrrolidines for the manufacture of medicaments for treating hyperlipidemia and associated diseases
GB9305295D0 (en) Therapeutic compounds
IL107287A (en) Heterocyclic derivatives process for their preparation and pharmaceutical compositions containing some of them
HK1014138A1 (en) Benzenesulphonamide derivatives for the treatment of bladder instability
WO2001085709A3 (en) New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing them
GEP20074058B (en) 4-(7-halo-2-quino(xa) linyloxy-phenoxy-propionic acid derivatives as antineoplastic agents
IL166057A0 (en) Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
YU66900A (sh) Derivati higromicina a
ATE554764T1 (de) Wirkungsvolle vereinfachte derivate von immunosuppressiva
IL159521A0 (en) Tricyclic pyridines for use in treatment of conditions mediated by crf
AP2001002154A0 (en) Hygromycin a derivatives (changed by the ISA to read hygromycin a derivatives as antibacterial agents.
MXPA04002784A (es) Sales farmaceuticamente aceptables de 20(s)-camptotecinas.
HRP20010845A9 (en) Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives
JO1697B1 (en) Pyridine derivatives